Landscape Capital Management L.L.C. Makes New $3.36 Million Investment in Envista Holdings Co. (NYSE:NVST)

Landscape Capital Management L.L.C. purchased a new stake in Envista Holdings Co. (NYSE:NVST - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 169,865 shares of the company's stock, valued at approximately $3,357,000. Landscape Capital Management L.L.C. owned about 0.10% of Envista at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. Jupiter Asset Management Ltd. bought a new position in shares of Envista during the second quarter worth $69,534,000. Pacer Advisors Inc. grew its holdings in shares of Envista by 11,202.8% in the 2nd quarter. Pacer Advisors Inc. now owns 2,887,426 shares of the company's stock valued at $48,018,000 after acquiring an additional 2,861,880 shares in the last quarter. Swedbank AB bought a new stake in shares of Envista during the 1st quarter worth approximately $53,412,000. Nuance Investments LLC grew its stake in shares of Envista by 47.2% in the second quarter. Nuance Investments LLC now owns 7,038,313 shares of the company's stock valued at $117,048,000 after buying an additional 2,256,993 shares in the last quarter. Finally, Ariel Investments LLC raised its position in Envista by 11.0% during the second quarter. Ariel Investments LLC now owns 9,871,152 shares of the company's stock worth $164,157,000 after acquiring an additional 978,952 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on NVST shares. Piper Sandler raised their target price on shares of Envista from $16.00 to $17.00 and gave the company a "neutral" rating in a research note on Thursday, October 31st. Leerink Partners raised Envista from an "underperform" rating to a "market perform" rating and raised their price target for the company from $16.00 to $23.00 in a report on Thursday, October 31st. Evercore ISI upped their price objective on shares of Envista from $18.00 to $23.00 and gave the company an "outperform" rating in a report on Monday, September 23rd. Wells Fargo & Company initiated coverage on shares of Envista in a research note on Tuesday, October 8th. They set an "equal weight" rating and a $20.00 target price for the company. Finally, Leerink Partnrs upgraded shares of Envista from a "strong sell" rating to a "hold" rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $20.71.

Envista Price Performance

NVST opened at $20.37 on Thursday. The business's fifty day moving average is $19.38 and its 200-day moving average is $18.14. Envista Holdings Co. has a 52-week low of $15.15 and a 52-week high of $25.64. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77.

Envista (NYSE:NVST - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.09 by $0.03. The company had revenue of $601.00 million during the quarter, compared to analysts' expectations of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The business's revenue for the quarter was down 4.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.43 EPS. Sell-side analysts forecast that Envista Holdings Co. will post 0.72 earnings per share for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.